Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Human Prothrombin Complex Market Research Report 2025

Global Human Prothrombin Complex Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 86 Pages

Report ld: 3472396

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Human Prothrombin Complex Market Size(US$)

CAGR 2025-2031

11.8%

Market Size,2031

USD 4,251

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 2,177 million

Market Forecast in 2031(Value)

US$ 4,251 million

CAGR

11.8%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.

The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Prothrombin Complex manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Takeda

CSL

Grifols

Octapharma

Hualan Biological

Meheco Xinxing Pharma

Segment by Type

500 IU/Vial

600 IU/Vial

1000 IU/Vial

Others

Segment by Application

Hemophilia B

Vitamin K Deficiency

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Human Prothrombin Complex in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Human Prothrombin Complex Market Overview

1.1 Product Definition

1.2 Human Prothrombin Complex by Type

1.2.1 Global Human Prothrombin Complex Market Value Comparison by Type (2024 VS 2031)

1.2.2 500 IU/Vial

1.2.3 600 IU/Vial

1.2.4 1000 IU/Vial

1.2.5 Others

1.3 Human Prothrombin Complex by Application

1.3.1 Global Human Prothrombin Complex Market Value by Application (2024 VS 2031)

1.3.2 Hemophilia B

1.3.3 Vitamin K Deficiency

1.3.4 Others

1.4 Global Human Prothrombin Complex Market Size Estimates and Forecasts

1.4.1 Global Human Prothrombin Complex Revenue 2020-2031

1.4.2 Global Human Prothrombin Complex Sales 2020-2031

1.4.3 Global Human Prothrombin Complex Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Human Prothrombin Complex Market Competition by Manufacturers

2.1 Global Human Prothrombin Complex Sales Market Share by Manufacturers (2020-2025)

2.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Human Prothrombin Complex Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Human Prothrombin Complex, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Prothrombin Complex, Product Type & Application

2.7 Global Key Manufacturers of Human Prothrombin Complex, Date of Enter into This Industry

2.8 Global Human Prothrombin Complex Market Competitive Situation and Trends

2.8.1 Global Human Prothrombin Complex Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Human Prothrombin Complex Players Market Share by Revenue

2.8.3 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Human Prothrombin Complex Market Scenario by Region

3.1 Global Human Prothrombin Complex Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Human Prothrombin Complex Sales by Region: 2020-2031

3.2.1 Global Human Prothrombin Complex Sales by Region: 2020-2025

3.2.2 Global Human Prothrombin Complex Sales by Region: 2026-2031

3.3 Global Human Prothrombin Complex Revenue by Region: 2020-2031

3.3.1 Global Human Prothrombin Complex Revenue by Region: 2020-2025

3.3.2 Global Human Prothrombin Complex Revenue by Region: 2026-2031

3.4 North America Human Prothrombin Complex Market Facts & Figures by Country

3.4.1 North America Human Prothrombin Complex Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Human Prothrombin Complex Sales by Country (2020-2031)

3.4.3 North America Human Prothrombin Complex Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Human Prothrombin Complex Market Facts & Figures by Country

3.5.1 Europe Human Prothrombin Complex Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Human Prothrombin Complex Sales by Country (2020-2031)

3.5.3 Europe Human Prothrombin Complex Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Prothrombin Complex Market Facts & Figures by Region

3.6.1 Asia Pacific Human Prothrombin Complex Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Human Prothrombin Complex Sales by Region (2020-2031)

3.6.3 Asia Pacific Human Prothrombin Complex Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Human Prothrombin Complex Market Facts & Figures by Country

3.7.1 Latin America Human Prothrombin Complex Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Human Prothrombin Complex Sales by Country (2020-2031)

3.7.3 Latin America Human Prothrombin Complex Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Human Prothrombin Complex Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Prothrombin Complex Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Human Prothrombin Complex Sales by Country (2020-2031)

3.8.3 Middle East and Africa Human Prothrombin Complex Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Human Prothrombin Complex Sales by Type (2020-2031)

4.1.1 Global Human Prothrombin Complex Sales by Type (2020-2025)

4.1.2 Global Human Prothrombin Complex Sales by Type (2026-2031)

4.1.3 Global Human Prothrombin Complex Sales Market Share by Type (2020-2031)

4.2 Global Human Prothrombin Complex Revenue by Type (2020-2031)

4.2.1 Global Human Prothrombin Complex Revenue by Type (2020-2025)

4.2.2 Global Human Prothrombin Complex Revenue by Type (2026-2031)

4.2.3 Global Human Prothrombin Complex Revenue Market Share by Type (2020-2031)

4.3 Global Human Prothrombin Complex Price by Type (2020-2031)

5 Segment by Application

5.1 Global Human Prothrombin Complex Sales by Application (2020-2031)

5.1.1 Global Human Prothrombin Complex Sales by Application (2020-2025)

5.1.2 Global Human Prothrombin Complex Sales by Application (2026-2031)

5.1.3 Global Human Prothrombin Complex Sales Market Share by Application (2020-2031)

5.2 Global Human Prothrombin Complex Revenue by Application (2020-2031)

5.2.1 Global Human Prothrombin Complex Revenue by Application (2020-2025)

5.2.2 Global Human Prothrombin Complex Revenue by Application (2026-2031)

5.2.3 Global Human Prothrombin Complex Revenue Market Share by Application (2020-2031)

5.3 Global Human Prothrombin Complex Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Takeda

6.1.1 Takeda Company Information

6.1.2 Takeda Description and Business Overview

6.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Takeda Human Prothrombin Complex Product Portfolio

6.1.5 Takeda Recent Developments/Updates

6.2 CSL

6.2.1 CSL Company Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CSL Human Prothrombin Complex Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 Grifols

6.3.1 Grifols Company Information

6.3.2 Grifols Description and Business Overview

6.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Grifols Human Prothrombin Complex Product Portfolio

6.3.5 Grifols Recent Developments/Updates

6.4 Octapharma

6.4.1 Octapharma Company Information

6.4.2 Octapharma Description and Business Overview

6.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Octapharma Human Prothrombin Complex Product Portfolio

6.4.5 Octapharma Recent Developments/Updates

6.5 Hualan Biological

6.5.1 Hualan Biological Company Information

6.5.2 Hualan Biological Description and Business Overview

6.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio

6.5.5 Hualan Biological Recent Developments/Updates

6.6 Meheco Xinxing Pharma

6.6.1 Meheco Xinxing Pharma Company Information

6.6.2 Meheco Xinxing Pharma Description and Business Overview

6.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio

6.6.5 Meheco Xinxing Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Human Prothrombin Complex Industry Chain Analysis

7.2 Human Prothrombin Complex Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Prothrombin Complex Production Mode & Process Analysis

7.4 Human Prothrombin Complex Sales and Marketing

7.4.1 Human Prothrombin Complex Sales Channels

7.4.2 Human Prothrombin Complex Distributors

7.5 Human Prothrombin Complex Customer Analysis

8 Human Prothrombin Complex Market Dynamics

8.1 Human Prothrombin Complex Industry Trends

8.2 Human Prothrombin Complex Market Drivers

8.3 Human Prothrombin Complex Market Challenges

8.4 Human Prothrombin Complex Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Human Prothrombin Complex Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Human Prothrombin Complex Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Human Prothrombin Complex Market Competitive Situation by Manufacturers in 2024

Table 4. Global Human Prothrombin Complex Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Human Prothrombin Complex Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Human Prothrombin Complex Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Human Prothrombin Complex Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Human Prothrombin Complex Average Price (M USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Human Prothrombin Complex, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Human Prothrombin Complex, Product Type & Application

Table 12. Global Key Manufacturers of Human Prothrombin Complex, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Prothrombin Complex Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Human Prothrombin Complex Sales by Region (2020-2025) & (K Units)

Table 18. Global Human Prothrombin Complex Sales Market Share by Region (2020-2025)

Table 19. Global Human Prothrombin Complex Sales by Region (2026-2031) & (K Units)

Table 20. Global Human Prothrombin Complex Sales Market Share by Region (2026-2031)

Table 21. Global Human Prothrombin Complex Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Human Prothrombin Complex Revenue Market Share by Region (2020-2025)

Table 23. Global Human Prothrombin Complex Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Human Prothrombin Complex Revenue Market Share by Region (2026-2031)

Table 25. North America Human Prothrombin Complex Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)

Table 27. North America Human Prothrombin Complex Sales by Country (2026-2031) & (K Units)

Table 28. North America Human Prothrombin Complex Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Human Prothrombin Complex Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Human Prothrombin Complex Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)

Table 32. Europe Human Prothrombin Complex Sales by Country (2026-2031) & (K Units)

Table 33. Europe Human Prothrombin Complex Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Human Prothrombin Complex Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Human Prothrombin Complex Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Human Prothrombin Complex Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Human Prothrombin Complex Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Human Prothrombin Complex Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Human Prothrombin Complex Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human Prothrombin Complex Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Human Prothrombin Complex Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Human Prothrombin Complex Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Human Prothrombin Complex Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Human Prothrombin Complex Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Human Prothrombin Complex Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Human Prothrombin Complex Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Human Prothrombin Complex Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Human Prothrombin Complex Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Human Prothrombin Complex Sales (K Units) by Type (2020-2025)

Table 51. Global Human Prothrombin Complex Sales (K Units) by Type (2026-2031)

Table 52. Global Human Prothrombin Complex Sales Market Share by Type (2020-2025)

Table 53. Global Human Prothrombin Complex Sales Market Share by Type (2026-2031)

Table 54. Global Human Prothrombin Complex Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Human Prothrombin Complex Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Human Prothrombin Complex Revenue Market Share by Type (2020-2025)

Table 57. Global Human Prothrombin Complex Revenue Market Share by Type (2026-2031)

Table 58. Global Human Prothrombin Complex Price (M USD/Unit) by Type (2020-2025)

Table 59. Global Human Prothrombin Complex Price (M USD/Unit) by Type (2026-2031)

Table 60. Global Human Prothrombin Complex Sales (K Units) by Application (2020-2025)

Table 61. Global Human Prothrombin Complex Sales (K Units) by Application (2026-2031)

Table 62. Global Human Prothrombin Complex Sales Market Share by Application (2020-2025)

Table 63. Global Human Prothrombin Complex Sales Market Share by Application (2026-2031)

Table 64. Global Human Prothrombin Complex Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Human Prothrombin Complex Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Human Prothrombin Complex Revenue Market Share by Application (2020-2025)

Table 67. Global Human Prothrombin Complex Revenue Market Share by Application (2026-2031)

Table 68. Global Human Prothrombin Complex Price (M USD/Unit) by Application (2020-2025)

Table 69. Global Human Prothrombin Complex Price (M USD/Unit) by Application (2026-2031)

Table 70. Takeda Company Information

Table 71. Takeda Description and Business Overview

Table 72. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)

Table 73. Takeda Human Prothrombin Complex Product

Table 74. Takeda Recent Developments/Updates

Table 75. CSL Company Information

Table 76. CSL Description and Business Overview

Table 77. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)

Table 78. CSL Human Prothrombin Complex Product

Table 79. CSL Recent Developments/Updates

Table 80. Grifols Company Information

Table 81. Grifols Description and Business Overview

Table 82. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)

Table 83. Grifols Human Prothrombin Complex Product

Table 84. Grifols Recent Developments/Updates

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)

Table 88. Octapharma Human Prothrombin Complex Product

Table 89. Octapharma Recent Developments/Updates

Table 90. Hualan Biological Company Information

Table 91. Hualan Biological Description and Business Overview

Table 92. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)

Table 93. Hualan Biological Human Prothrombin Complex Product

Table 94. Hualan Biological Recent Developments/Updates

Table 95. Meheco Xinxing Pharma Company Information

Table 96. Meheco Xinxing Pharma Description and Business Overview

Table 97. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)

Table 98. Meheco Xinxing Pharma Human Prothrombin Complex Product

Table 99. Meheco Xinxing Pharma Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Human Prothrombin Complex Distributors List

Table 103. Human Prothrombin Complex Customers List

Table 104. Human Prothrombin Complex Market Trends

Table 105. Human Prothrombin Complex Market Drivers

Table 106. Human Prothrombin Complex Market Challenges

Table 107. Human Prothrombin Complex Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Human Prothrombin Complex

Figure 2. Global Human Prothrombin Complex Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Prothrombin Complex Market Share by Type: 2024 & 2031

Figure 4. 500 IU/Vial Product Picture

Figure 5. 600 IU/Vial Product Picture

Figure 6. 1000 IU/Vial Product Picture

Figure 7. Others Product Picture

Figure 8. Global Human Prothrombin Complex Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Human Prothrombin Complex Market Share by Application: 2024 & 2031

Figure 10. Hemophilia B

Figure 11. Vitamin K Deficiency

Figure 12. Others

Figure 13. Global Human Prothrombin Complex Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Human Prothrombin Complex Market Size (2020-2031) & (US$ Million)

Figure 15. Global Human Prothrombin Complex Sales (2020-2031) & (K Units)

Figure 16. Global Human Prothrombin Complex Average Price (M USD/Unit) & (2020-2031)

Figure 17. Human Prothrombin Complex Report Years Considered

Figure 18. Human Prothrombin Complex Sales Share by Manufacturers in 2024

Figure 19. Global Human Prothrombin Complex Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Human Prothrombin Complex Players: Market Share by Revenue in Human Prothrombin Complex in 2024

Figure 21. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Human Prothrombin Complex Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Human Prothrombin Complex Sales Market Share by Country (2020-2031)

Figure 24. North America Human Prothrombin Complex Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Human Prothrombin Complex Sales Market Share by Country (2020-2031)

Figure 28. Europe Human Prothrombin Complex Revenue Market Share by Country (2020-2031)

Figure 29. Germany Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Human Prothrombin Complex Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Human Prothrombin Complex Revenue Market Share by Region (2020-2031)

Figure 36. China Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Human Prothrombin Complex Sales Market Share by Country (2020-2031)

Figure 46. Latin America Human Prothrombin Complex Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Human Prothrombin Complex Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Human Prothrombin Complex Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Human Prothrombin Complex Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Human Prothrombin Complex by Type (2020-2031)

Figure 56. Global Revenue Market Share of Human Prothrombin Complex by Type (2020-2031)

Figure 57. Global Human Prothrombin Complex Price (M USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Human Prothrombin Complex by Application (2020-2031)

Figure 59. Global Revenue Market Share of Human Prothrombin Complex by Application (2020-2031)

Figure 60. Global Human Prothrombin Complex Price (M USD/Unit) by Application (2020-2031)

Figure 61. Human Prothrombin Complex Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Human Prothrombin Complex market? zhanKai

The top companies in the global Human Prothrombin Complex market are Takeda、CSL、Grifols.

What was the global market size of Human Prothrombin Complex in 2031? shouQi

What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Human Prothrombin Complex in 2025? shouQi

Related Reports

Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)

Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
USD 4250.00 (Single User License)
Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
USD 3950.00 (Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
USD 4900.00 (Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
USD 3950.00 (Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)